Search results
Pathology Asia believes it takes a doctor to know a doctor. That's why we are medically managed with doctors at the centre of decision making. Our mission is to make high quality diagnostic services accessible and affordable throughout Southeast Asia’s c.680 million population.
Pathology Asia is founded with the acquisition of Gribbles Pathology, Quantum Diagnostics, Innovative Diagnostics and Quest Laboratories by TPG Capital. 2019 Pathology Asia acquires Safework Laboratories in Australia; and Clinipath in Malaysia.
Pathology Asia is headquartered in Singapore with a presence in Southeast Asia and Australia. Our laboratories include Innoquest Diagnostics, one of the largest diagnostic service providers in Singapore; Innoquest Pathology (formerly Gribbles Pathology), a market leader in Malaysia; and Safework Health, a leading occupational health provider ...
Dec 9, 2021 · SINGAPORE: Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering (IPO) for the unit, according to ...
Company profile page for Pathology Asia Holdings Pte Ltd including stock price, company news, executives, board members, and contact information
Dec 8, 2021 · Deal Wrap is updated as of 4 p.m. ET. * TPG Capital LP's Asian arm is looking to potentially sell a 20% stake in Pathology Asia Holdings Pte. Ltd. in advance of a possible IPO for the business, Bloomberg News reported, citing people with knowledge of the matter.
Dec 8, 2021 · Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering for the unit, according to people with ...
Jan 19, 2022 · (Bloomberg) -- Private equity firm TPG Capital Asia is close to an agreement to sell a minority stake in Pathology Asia Holdings Pte in a deal that values the health-care business at about $2 billion, according to people with knowledge of the matter.
Mar 26, 2021 · TPG Capital Asia has picked banks to help prepare an initial public offering of its pathology business in the region that could raise as much as $594 million in Singapore, according to people with knowledge of the matter.
Mar 5, 2021 · Pathology Asia Holdings, originally formed out of the Healthscope purchase, includes the Quest Laboratories brand in Singapore and Vietnam, and Gribbles Pathology in Malaysia.
